Search
An enzyme that contributes to plaque formation in the brain also serves as a first line of defense against bacteria and viruses, suggesting a link between the two.
Memorial Sloan Kettering’s vision is nothing less than to revolutionize the treatment of cancer. Learn about some of the ways we’re doing it.
Each year since 2007, Memorial Sloan Kettering's postdoctoral researchers have had the opportunity to showcase their research accomplishments at the annual Postdoctoral Research Symposium.
Memorial Sloan Kettering has made an important step forward in efficiently diagnosing gene mutations in patients' cancers on an individual basis.
During World War II, US factories famously converted their operations to support the war effort. COVID-19 instigated something similar among cancer scientists.
A number of Gerstner Sloan Kettering students working in labs across MSK have received prestigious fellowships granted by external agencies and benefactors of the school.
Charles L. Sawyers, Chair of the Human Oncology and Pathogenesis Program, is a co-recipient of the 2011 Stanley J. Korsmeyer Award from the American Society for Clinical Investigation.
The Gerstner Sloan Kettering Graduate School of Biomedical Sciences welcomes 21 students to the Summer Undergraduate Research Program.
Investigators have sequenced the genome of adenoid cystic carcinoma, a rare and deadly head and neck cancer. The work sets the stage for the sequencing of additional rare cancers at Memorial Sloan Kettering.
Sloan Kettering Institute scientists report new findings about a gene that helps regulate DNA methylation.